Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mhairi Nimick

ALK and IGF-1R as Independent Targets in Crizotinib Resistant Lung Cancer

Scientific Reports

Multidisciplinary

English

Related publications

P2.01-89 Synergistic Cytotoxicity Through MAPK/ERK Pathway and ALK Inhibition in Crizotinib Resistant EML4-ALK-Positive Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Heterogeneous Responses and Resistant Mechanisms to Crizotinib in ALK -Positive Advanced Non-Small Cell Lung Cancer

Thoracic Cancer

Respiratory Medicine

English

Alectinib in ALK -Positive, Crizotinib-Resistant, Non-Small-Cell Lung Cancer: A Single-Group, Multicentre, Phase 2 Trial

The Lancet Oncology

English

IGF-1R as an Anti-Cancer Target--Trials and Tribulations

Chinese Journal of Cancer

English

Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer

Journal of Clinical Oncology

Cancer Research

English

Revisiting the IGF-1R as a Breast Cancer Target

npj Precision Oncology

English

Molecular Imaging of IGF-1R in Cancer

Molecular Imaging

Nuclear Medicine

Molecular Medicine

Condensed Matter Physics

Biomedical Engineering

English

P2.13-07 CUX1-ALK: A Novel ALK Rearrangement That Responds to Crizotinib in Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Outcomes of ALK Positive Lung Cancer Patients Treated With Crizotinib or Second-Generation ALK Inhibitor: A Monoinstitutional Experience

English